COVID-19 & Ukraine War Underpin EU Moves To Secure Medicines Supply

 
• By Ian Schofield

Concerns by the drug industry over “complex and burdensome” regulatory requirements regarding security of supply could be addressed in the upcoming revision of the EU pharmaceutical legislation, suggests a report on the European Commission’s “structured dialog” process for tackling medicine supply chain vulnerabilities.

Filling vials
The commission has proposed actions to address weaknesses in the medicines supply chain • Source: Shutterstock

More from Distribution/Supply Chain

More from Compliance